Literature DB >> 23842677

Differential control of metabolic and cardiovascular functions by melanocortin-4 receptors in proopiomelanocortin neurons.

Jussara M do Carmo1, Alexandre A da Silva, John S Rushing, Benjamin Pace, John E Hall.   

Abstract

We examined the role of melanocortin-4 receptors (MC4R) in proopiomelanocortin (Pomc) neurons in regulating metabolic and cardiovascular functions. Using Cre-loxP technology, we selectively rescued MC4R in Pomc neurons of mice with whole body MC4R deficiency (MC4R-Pomc-Cre mice). Body weight, food intake, and whole body oxygen consumption (Vo2) were determined daily, and blood pressure (BP), heart rate (HR), and body temperature were measured 24 h/day by telemetry. An intracerebroventricular cannula was placed in the right lateral ventricle for intracerebroventricular infusions. Littermate MC4R-deficient (LoxTB-MC4R) mice were used as controls. After control measurements, the MC4R antagonist (SHU-9119; 1 nmol/h) was infused intracerebroventricularly for 7 days. Compared with LoxTB-MC4R mice, MC4R-Pomc-Cre mice were less obese (47 ± 2 vs. 52 ± 2 g) and had increased energy expenditure (2,174 ± 98 vs. 1,990 ± 68 ml·kg⁻¹·min⁻¹), but food intake (4.4 ± 0.2 vs. 4.3 ± 0.3 g/day), BP (112 ± 1 vs. 109 ± 3 mmHg), and HR [557 ± 9 vs. 551 ± 14 beats per minute (bpm)] were similar between groups. Chronic SHU-9119 infusion increased food intake (4.2 ± 0.2 to 6.1 ± 0.5 g/day) and body weight (47 ± 2 to 52 ± 2 g) in MC4R-Pomc-Cre mice, while no changes were observed in LoxTB-MC4R mice. Chronic SHU-9119 infusion also increased BP and HR by 5 ± 1 mmHg and 60 ± 8 bpm in MC4R-Pomc-Cre mice without altering BP or HR in LoxTB-MC4R mice. These results indicate that MC4Rs in Pomc neurons are important for regulation of energy balance. In contrast, while activation of MC4R in Pomc neurons facilitates the BP response to acute stress, our data do not support a major role of MC4R in Pomc neurons in regulating baseline BP and HR.

Entities:  

Keywords:  blood pressure; energy expenditure; heart rate; hypertension; melanocortin; obesity; sympathetic nervous system

Mesh:

Substances:

Year:  2013        PMID: 23842677      PMCID: PMC3833394          DOI: 10.1152/ajpregu.00518.2012

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  24 in total

1.  Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin.

Authors:  Lakshmi S Tallam; Alexandre A da Silva; John E Hall
Journal:  Hypertension       Date:  2006-06-05       Impact factor: 10.190

2.  Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity.

Authors:  Leona Plum; Xiaosong Ma; Brigitte Hampel; Nina Balthasar; Roberto Coppari; Heike Münzberg; Marya Shanabrough; Denis Burdakov; Eva Rother; Ruth Janoschek; Jens Alber; Bengt F Belgardt; Linda Koch; Jost Seibler; Frieder Schwenk; Csaba Fekete; Akira Suzuki; Tak W Mak; Wilhelm Krone; Tamas L Horvath; Frances M Ashcroft; Jens C Brüning
Journal:  J Clin Invest       Date:  2006-06-22       Impact factor: 14.808

3.  Melanocortins and agouti-related protein modulate the excitability of two arcuate nucleus neuron populations by alteration of resting potassium conductances.

Authors:  Mark A Smith; Kazunari Hisadome; Hind Al-Qassab; Helen Heffron; Dominic J Withers; Michael L J Ashford
Journal:  J Physiol       Date:  2006-10-26       Impact factor: 5.182

Review 4.  Post-translational processing of proopiomelanocortin in the pituitary and in the brain.

Authors:  M G Castro; E Morrison
Journal:  Crit Rev Neurobiol       Date:  1997

5.  Does obesity induce resistance to the long-term cardiovascular and metabolic actions of melanocortin 3/4 receptor activation?

Authors:  Alexandre A da Silva; Jay J Kuo; Lakshmi S Tallam; Jiankang Liu; John E Hall
Journal:  Hypertension       Date:  2005-12-27       Impact factor: 10.190

6.  Divergence of melanocortin pathways in the control of food intake and energy expenditure.

Authors:  Nina Balthasar; Louise T Dalgaard; Charlotte E Lee; Jia Yu; Hisayuki Funahashi; Todd Williams; Manuel Ferreira; Vinsee Tang; Robert A McGovern; Christopher D Kenny; Lauryn M Christiansen; Elizabeth Edelstein; Brian Choi; Olivier Boss; Carl Aschkenasi; Chen-yu Zhang; Kathleen Mountjoy; Toshiro Kishi; Joel K Elmquist; Bradford B Lowell
Journal:  Cell       Date:  2005-11-04       Impact factor: 41.582

7.  Role of nitric oxide in alpha-melanocyte-stimulating hormone-induced hypotension in the nucleus tractus solitarii of the spontaneously hypertensive rats.

Authors:  Ming-Hong Tai; Wen-Tsan Weng; Wan-Chen Lo; Julie Y H Chan; Che-Jen Lin; Hing-Chung Lam; Ching-Jiunn Tseng
Journal:  J Pharmacol Exp Ther       Date:  2007-02-05       Impact factor: 4.030

8.  Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.

Authors:  K G Mountjoy; M T Mortrud; M J Low; R B Simerly; R D Cone
Journal:  Mol Endocrinol       Date:  1994-10

9.  Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin.

Authors:  Alexandre A da Silva; Jay J Kuo; John E Hall
Journal:  Hypertension       Date:  2004-05-03       Impact factor: 10.190

10.  Thermogenesis activated by central melanocortin signaling is dependent on neurons in the rostral raphe pallidus (rRPa) area.

Authors:  Wei Fan; Shaun F Morrison; Wei-Hua Cao; Pinxuan Yu
Journal:  Brain Res       Date:  2007-04-06       Impact factor: 3.252

View more
  19 in total

1.  The change in cerebral glucose metabolism after electroacupuncture: a possible marker to predict the therapeutic effect of deep brain stimulation for refractory anorexia nervosa.

Authors:  Tao-Tao Liu; Qing-Xiong Hong; Hong-Bing Xiang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Role of hindbrain melanocortin-4 receptor activity in controlling cardiovascular and metabolic functions in spontaneously hypertensive rats.

Authors:  Jussara M do Carmo; Alexandre A da Silva; John E Hall
Journal:  J Hypertens       Date:  2015-06       Impact factor: 4.844

Review 3.  The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases.

Authors:  Minying Cai; Victor J Hruby
Journal:  Curr Protein Pept Sci       Date:  2016       Impact factor: 3.272

4.  Obesity-associated extracellular mtDNA activates central TGFβ pathway to cause blood pressure increase.

Authors:  Albert Alé; Yalin Zhang; Cheng Han; Dongsheng Cai
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-11-15       Impact factor: 4.310

Review 5.  Role of the brain melanocortins in blood pressure regulation.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Taolin Fang; Nicola Aberdein; Cecilia E Perez de Lara; John E Hall
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-06       Impact factor: 5.187

Review 6.  Melanocortin-4 Receptors and Sympathetic Nervous System Activation in Hypertension.

Authors:  Alexandre A da Silva; Jussara M do Carmo; Zhen Wang; John E Hall
Journal:  Curr Hypertens Rep       Date:  2019-04-26       Impact factor: 5.369

Review 7.  Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens.

Authors:  Licy L Yanes Cardozo; Damian G Romero; Jane F Reckelhoff
Journal:  Physiology (Bethesda)       Date:  2017-09

Review 8.  The brain melanocortin system, sympathetic control, and obesity hypertension.

Authors:  Alexandre A da Silva; Jussara M do Carmo; Zhen Wang; John E Hall
Journal:  Physiology (Bethesda)       Date:  2014-05

9.  Control of appetite, blood glucose, and blood pressure during melanocortin-4 receptor activation in normoglycemic and diabetic NPY-deficient mice.

Authors:  Alexandre A da Silva; J Nathan Freeman; John E Hall; Jussara M do Carmo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-12-20       Impact factor: 3.619

Review 10.  Biased signaling at neural melanocortin receptors in regulation of energy homeostasis.

Authors:  Li-Kun Yang; Ya-Xiong Tao
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-04-19       Impact factor: 5.187

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.